Antinociception and anti-inflammation induced by simvastatin in algesiometric assays in mice

Hugo F. Miranda, Viviana Noriega, Loreto Olavarria, Ramiro J. Zepeda, Fernando Sierralta, Juan C. Prieto

Resultado de la investigación: Article

15 Citas (Scopus)

Resumen

Statins, belonging to a well-known drug class used for lowering cholesterol through competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, also have other pleiotropic properties, such as anti-inflammatory action. The purpose of this study was to evaluate the antinociceptive and anti-inflammatory effects of simvastatin in five models of nociceptive behaviour. Oral gavage administration of simvastatin induced a dose-dependent inhibition of nociception for 1day in the acetic acid writhing (ED 50=5.59±0.07), tail-flick (ED 50=112.96±8.00), hot-plate (ED 50= 134.87±2.20), formalin hind paw (ED 50=19.86±1.12 in phase I and 23.30±2.05 in phase II) and orofacial formalin (ED 50=5.54±2.74 in phase I and 11.48±1.88 in phase II) tests. However, after 3days, the values were in the acetic acid writhing (ED 50=6.14±0.51), tail-flick (ED 50=154±8.88), hot-plate (ED 50=136.14±2.94), formalin hind paw (ED 50=15.93±0.42 in phase I and 17.10±1.80 in phase II) and orofacial formalin (ED 50=6.79±0.66 in phase I and 5.80±1.49 in phase II) tests. This study demonstrated the antinociceptive and anti-inflammatory activities of simvastatin in five models of tonic or phasic pain. These actions seem to be related to the inhibition of cytokine and prostanoid release and stimulation of nitric oxide synthesis. A possible clinical role of simvastatin could be related to the potentially beneficial effects in the neuropathic pain, and by their pleiotropic properties, they could play a clinical role in anti-inflammatory disease.

Idioma originalEnglish
Páginas (desde-hasta)438-442
Número de páginas5
PublicaciónBasic and Clinical Pharmacology and Toxicology
Volumen109
N.º6
DOI
EstadoPublished - dic 2011

Huella dactilar

Simvastatin
Formaldehyde
Assays
Anti-Inflammatory Agents
Inflammation
Acetic Acid
Tail
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Nociception
Neuralgia
Prostaglandins
Oral Administration
Oxidoreductases
Nitric Oxide
Cholesterol
Cytokines
Pain
Pharmaceutical Preparations
Inhibition (Psychology)

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology
  • Medicine(all)

Citar esto

Miranda, Hugo F. ; Noriega, Viviana ; Olavarria, Loreto ; Zepeda, Ramiro J. ; Sierralta, Fernando ; Prieto, Juan C. / Antinociception and anti-inflammation induced by simvastatin in algesiometric assays in mice. En: Basic and Clinical Pharmacology and Toxicology. 2011 ; Vol. 109, N.º 6. pp. 438-442.
@article{70d4ca107c2a4377b7ac6b82f108cf9e,
title = "Antinociception and anti-inflammation induced by simvastatin in algesiometric assays in mice",
abstract = "Statins, belonging to a well-known drug class used for lowering cholesterol through competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, also have other pleiotropic properties, such as anti-inflammatory action. The purpose of this study was to evaluate the antinociceptive and anti-inflammatory effects of simvastatin in five models of nociceptive behaviour. Oral gavage administration of simvastatin induced a dose-dependent inhibition of nociception for 1day in the acetic acid writhing (ED 50=5.59±0.07), tail-flick (ED 50=112.96±8.00), hot-plate (ED 50= 134.87±2.20), formalin hind paw (ED 50=19.86±1.12 in phase I and 23.30±2.05 in phase II) and orofacial formalin (ED 50=5.54±2.74 in phase I and 11.48±1.88 in phase II) tests. However, after 3days, the values were in the acetic acid writhing (ED 50=6.14±0.51), tail-flick (ED 50=154±8.88), hot-plate (ED 50=136.14±2.94), formalin hind paw (ED 50=15.93±0.42 in phase I and 17.10±1.80 in phase II) and orofacial formalin (ED 50=6.79±0.66 in phase I and 5.80±1.49 in phase II) tests. This study demonstrated the antinociceptive and anti-inflammatory activities of simvastatin in five models of tonic or phasic pain. These actions seem to be related to the inhibition of cytokine and prostanoid release and stimulation of nitric oxide synthesis. A possible clinical role of simvastatin could be related to the potentially beneficial effects in the neuropathic pain, and by their pleiotropic properties, they could play a clinical role in anti-inflammatory disease.",
author = "Miranda, {Hugo F.} and Viviana Noriega and Loreto Olavarria and Zepeda, {Ramiro J.} and Fernando Sierralta and Prieto, {Juan C.}",
year = "2011",
month = "12",
doi = "10.1111/j.1742-7843.2011.00746.x",
language = "English",
volume = "109",
pages = "438--442",
journal = "Basic and Clinical Pharmacology and Toxicology",
issn = "1742-7835",
publisher = "Wiley-Blackwell",
number = "6",

}

Antinociception and anti-inflammation induced by simvastatin in algesiometric assays in mice. / Miranda, Hugo F.; Noriega, Viviana; Olavarria, Loreto; Zepeda, Ramiro J.; Sierralta, Fernando; Prieto, Juan C.

En: Basic and Clinical Pharmacology and Toxicology, Vol. 109, N.º 6, 12.2011, p. 438-442.

Resultado de la investigación: Article

TY - JOUR

T1 - Antinociception and anti-inflammation induced by simvastatin in algesiometric assays in mice

AU - Miranda, Hugo F.

AU - Noriega, Viviana

AU - Olavarria, Loreto

AU - Zepeda, Ramiro J.

AU - Sierralta, Fernando

AU - Prieto, Juan C.

PY - 2011/12

Y1 - 2011/12

N2 - Statins, belonging to a well-known drug class used for lowering cholesterol through competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, also have other pleiotropic properties, such as anti-inflammatory action. The purpose of this study was to evaluate the antinociceptive and anti-inflammatory effects of simvastatin in five models of nociceptive behaviour. Oral gavage administration of simvastatin induced a dose-dependent inhibition of nociception for 1day in the acetic acid writhing (ED 50=5.59±0.07), tail-flick (ED 50=112.96±8.00), hot-plate (ED 50= 134.87±2.20), formalin hind paw (ED 50=19.86±1.12 in phase I and 23.30±2.05 in phase II) and orofacial formalin (ED 50=5.54±2.74 in phase I and 11.48±1.88 in phase II) tests. However, after 3days, the values were in the acetic acid writhing (ED 50=6.14±0.51), tail-flick (ED 50=154±8.88), hot-plate (ED 50=136.14±2.94), formalin hind paw (ED 50=15.93±0.42 in phase I and 17.10±1.80 in phase II) and orofacial formalin (ED 50=6.79±0.66 in phase I and 5.80±1.49 in phase II) tests. This study demonstrated the antinociceptive and anti-inflammatory activities of simvastatin in five models of tonic or phasic pain. These actions seem to be related to the inhibition of cytokine and prostanoid release and stimulation of nitric oxide synthesis. A possible clinical role of simvastatin could be related to the potentially beneficial effects in the neuropathic pain, and by their pleiotropic properties, they could play a clinical role in anti-inflammatory disease.

AB - Statins, belonging to a well-known drug class used for lowering cholesterol through competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, also have other pleiotropic properties, such as anti-inflammatory action. The purpose of this study was to evaluate the antinociceptive and anti-inflammatory effects of simvastatin in five models of nociceptive behaviour. Oral gavage administration of simvastatin induced a dose-dependent inhibition of nociception for 1day in the acetic acid writhing (ED 50=5.59±0.07), tail-flick (ED 50=112.96±8.00), hot-plate (ED 50= 134.87±2.20), formalin hind paw (ED 50=19.86±1.12 in phase I and 23.30±2.05 in phase II) and orofacial formalin (ED 50=5.54±2.74 in phase I and 11.48±1.88 in phase II) tests. However, after 3days, the values were in the acetic acid writhing (ED 50=6.14±0.51), tail-flick (ED 50=154±8.88), hot-plate (ED 50=136.14±2.94), formalin hind paw (ED 50=15.93±0.42 in phase I and 17.10±1.80 in phase II) and orofacial formalin (ED 50=6.79±0.66 in phase I and 5.80±1.49 in phase II) tests. This study demonstrated the antinociceptive and anti-inflammatory activities of simvastatin in five models of tonic or phasic pain. These actions seem to be related to the inhibition of cytokine and prostanoid release and stimulation of nitric oxide synthesis. A possible clinical role of simvastatin could be related to the potentially beneficial effects in the neuropathic pain, and by their pleiotropic properties, they could play a clinical role in anti-inflammatory disease.

UR - http://www.scopus.com/inward/record.url?scp=81255160924&partnerID=8YFLogxK

U2 - 10.1111/j.1742-7843.2011.00746.x

DO - 10.1111/j.1742-7843.2011.00746.x

M3 - Article

C2 - 21699658

AN - SCOPUS:81255160924

VL - 109

SP - 438

EP - 442

JO - Basic and Clinical Pharmacology and Toxicology

JF - Basic and Clinical Pharmacology and Toxicology

SN - 1742-7835

IS - 6

ER -